Literature DB >> 6154100

Identification of a unique idiotype in cerebrospinal fluid and serum of a patient with multiple sclerosis.

L G Baird, T G Tachovsky, M Sandberg-Wollheim, H Koprowski, A Nisonoff.   

Abstract

Anti-idiotypic antibodies were prepared in mouse ascites fluid against the CSF-IgG of a patient with multiple sclerosis. After adsorption with pooled human IgG, the ascites fluid antibodies precipitated 20% of labeled autologous CSF IgG. By using a competitive radioimmunoassay, less than one microgram of unlabeled CSF IgG produced 50% inhibition of binding autologous 125I-labeled CSF IgG, whereas 50 micrograms of normal HIgG was not inhibitory. The idiotype could be found in both serum and CSF IgG and persisted over a 5-year period. The absolute concentration of idiotype in the CSF varied somewhat but remained from 4 to 10 times greater than that of the serum. One of 14 heterologous MS CSF was found to contain small amounts of inhibitory protein; eight CSF from patients with other neurologic diseases did not contain the idiotype.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154100

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Immunoglobulin idiotypes; experimental and clinical applications.

Authors:  A K Abbas
Journal:  Indian J Pediatr       Date:  1982 Sep-Oct       Impact factor: 1.967

2.  Anti-idiotypic antibodies induce neutralizing antibodies to rabies virus glycoprotein.

Authors:  K J Reagan; W H Wunner; T J Wiktor; H Koprowski
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

3.  Analysis of a predominant immunoglobulin population in the cerebrospinal fluid of a multiple sclerosis patient by means of an anti-idiotypic hybridoma antibody.

Authors:  W Gerhard; A Taylor; Z Wroblewska; M Sandberg-Wollheim; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

4.  Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.

Authors:  M J Walsh; W W Tourtellotte
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

Review 5.  Abnormalities of serum and plasma components in patients with multiple sclerosis.

Authors:  H C Ford
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.